Anti-aging, anti-inflammatory, moisturizing, soothing … so many cosmetic claims to be assessed from the first stages of an innovative cosmetic. The choice of efficacy tests is often too large and complex to quickly and inexpensively define the effect of a new active compound on the skin biology. StratiCELL offers to accelerate your innovation by coupling a transcriptomic screening to a proprietary database containing more than 3,500 genes organized by skin biology topics. This powerful analysis tool known as the StratiCELL Skin Knowledge Database (SSKDB) will accelerate the understanding of the mechanism of action of any new ingredient. Cosmetic objectivation is fast and focused, and total product launch time is reduced.
Read more about the SSKDB on http://StratiCELL.com/dna-microarray
Discover the full panel of in vitro efficacy testing by StratiCELL on https://StratiCELL.com
Contact the experts at info@StratiCELL.com
Kirsty Doolan 12 February 2025 We examine what's new in tropical and ingestible beauty products…
10 February 2025 IFF announces the launch of its new artificial intelligence (AI)-powered search tool:…
Renata Martins 6 February 2025 The global cosmetics market is evolving rapidly with an influx…
